Clinical Trials
19 trialsNCT05400603 2025-12-26
Aflac-NBL-2002
Emory University
Phase 1 Recruiting
NCT03173976 2025-11-06
Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial
University of Iowa
Phase 1 Active not recruiting
NCT02508038 2025-10-16
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
University of Wisconsin, Madison
Phase 1 Recruiting
NCT06513624 2025-07-25
ETC-159-02
National University Hospital, Singapore
Phase 1 Recruiting
NCT02517918 2025-06-08
METZOLIMOS
Institut Bergonié
Phase 1 Completed
NCT01671774 2024-11-14
PILOT
Astellas Pharma Inc
Phase 1 Completed
NCT00885326 2023-04-10
N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
NCT00424983 2020-12-21
Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year
Novartis
Phase 1 Completed
NCT00278434 2017-11-24
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
University of California, San Francisco
Phase 1 Terminated
NCT00582920 2015-12-24
Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01404702 2014-12-02
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
University of Alabama at Birmingham
Phase 1 Terminated
NCT00892242 2014-09-22
Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer
Washington University School of Medicine
Phase 1 Terminated
NCT00742924 2014-07-04
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
Children's Oncology Group
Phase 1 Completed
NCT00206388 2013-08-02
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
Baylor College of Medicine
Phase 1 Completed
NCT00004928 2013-06-19
Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00741377 2013-02-18
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
Novartis
Phase 1 Completed
NCT00258258 2013-02-01
Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
Roswell Park Cancer Institute
Phase 1 Terminated
NCT00264420 2010-12-21
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation
The Cleveland Clinic
Phase 1 Completed
NCT00415779 2010-02-24
ZANTE
National Cancer Institute, Naples
Phase 1 Completed